Why Is Insmed (INSM) Stock Up 134% Today?
Insmed(INSM) investorplace.com·2024-05-28 12:40Insmed (NASDAQ:INSM) stock is rising higher on Tuesday after the company announced positive results from a Phase 3 clinical trial of brensocatib in patients with non-cystic fibrosis bronchiectasis. This saw brensocatib reach its primary endpoint of statistically significant reductions in the annualized rate of pulmonary exacerbations (PEs) versus placebo. In addition to that, the study also met several of its secondary endpoints. James Chalmers, MBChB, Ph.D., Professor and Consultant Respiratory Physician a ...